Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Parkinson's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03845387
What this trial is testing

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

Who this might be right for
Parkinson Disease
Kissei Pharmaceutical Co., Ltd. 74
Not applicableStudy completedNCT04048265
What this trial is testing

TMS Treatment in Parkinson's Disease With Pain.

Who this might be right for
Transcranial Magnetic StimulationParkinson DiseasePain
Xuanwu Hospital, Beijing 52
Not applicableEnded earlyNCT01701128
What this trial is testing

The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Laval University 35
Testing effectiveness (Phase 2)Study completedNCT00224263
What this trial is testing

Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Xuanwu Hospital, Beijing 360
Testing effectiveness (Phase 2)Ended earlyNCT02906020
What this trial is testing

A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation

Who this might be right for
Parkinson's Disease
Genzyme, a Sanofi Company 273
Testing effectiveness (Phase 2)Study completedNCT06757010
What this trial is testing

NE3107 in Early Parkinson's

Who this might be right for
Parkinsons Disease (PD)
BioVie Inc. 57
Testing effectiveness (Phase 2)Study completedNCT01060878
What this trial is testing

Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)

Who this might be right for
Parkinson's Disease
Phytopharm 425
Early research (Phase 1)UnknownNCT02579473
What this trial is testing

Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Who this might be right for
Parkinson's Disease
Serina Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT02728843
What this trial is testing

Study of Parkinson's Early Stage With Deferiprone

Who this might be right for
Parkinson's Disease
ApoPharma 140
Large-scale testing (Phase 3)Study completedNCT00058838
What this trial is testing

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Pfizer 854
Large-scale testing (Phase 3)Study completedNCT00642889
What this trial is testing

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 227
Not applicableStudy completedNCT01380899
What this trial is testing

Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.

Who this might be right for
Parkinson DiseaseParkinsonian Disorders
Universidad Autonoma de San Luis Potosí 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT03100149
What this trial is testing

Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Hoffmann-La Roche 316
Large-scale testing (Phase 3)Study completedNCT02337725
What this trial is testing

TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Takeda 244
Not applicableNot Yet RecruitingNCT07604883
What this trial is testing

Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes

Who this might be right for
PARKINSON DISEASE (Disorder)Atypical ParkinsonismMultiple System Atrophy+2 more
International Institute of Molecular and Cell Biology in Warsaw 200
Large-scale testing (Phase 3)Study completedNCT05357989
What this trial is testing

Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Who this might be right for
Parkinson's Disease, Idiopathic
Annovis Bio Inc. 523
Not applicableActive Not RecruitingNCT06584383
What this trial is testing

A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's Disease

Who this might be right for
Parkinson Disease
InSightec 67
Not applicableUnknownNCT00271141
What this trial is testing

Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease

Who this might be right for
Parkinson's DiseaseOxidative Stress
Hillel Yaffe Medical Center 500
Testing effectiveness (Phase 2)Study completedNCT04928287
What this trial is testing

Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)

Who this might be right for
Parkinson Disease
Hope Biosciences Research Foundation 24
Testing effectiveness (Phase 2)Looking for participantsNCT07322887
What this trial is testing

Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
GEN İlaç ve Sağlık Ürünleri A.Ş. 45
Next Page